Bold Debates on the Future of Thrombectomy in Stroke: ESOC 2025
European Stroke Organisation (ESO) shared an insightful post on X:
”Couldn’t attend live? Explore one of the key discussions from Day 2 at ESOC 2025 in Helsinki. Our guests debate large core trial results: Are questions still open? Should thrombectomy be for all?”
Watch the key discussions here.
At ESOC 2025 in Helsinki, one of the key discussions on Day 2 centered on the evolving evidence from large core stroke trials.
Experts Anne Hege Nymoen Aamodt and Götz Thomalla debated whether current results fully address the complexities of patient selection and whether thrombectomy should be expanded to all patients.
The session highlighted ongoing uncertainties and the need for further research to refine treatment strategies in this challenging stroke population.
Do not miss the latest updates on global discussions, stay tuned with Hemostasis Today.
-
Oct 3, 2026, 14:07Roberto Pecoits-Filho: The Future Of Integrated Cardiovascular-Kidney-Metabolic Care
-
Oct 3, 2026, 14:04Denis Oduor: Building Community Partnerships to Guarantee Safe Blood Transfusion Access
-
Oct 3, 2026, 13:55Sex Differences In Secondary Stroke Prevention – European Stroke Organisation
-
Oct 3, 2026, 13:16Highlights and Care Insights from Day 1 at EHC 2026 – European Haemophilia Consortium
-
Oct 3, 2026, 12:11Adam Urato: Understanding SSRI Impacts on Maternal and Fetal Serotonin Levels
-
Oct 3, 2026, 12:02Cedric Hermans: How Should We Define Success in Haemophilia Care beyond Bleeding Rates?
-
Oct 3, 2026, 08:31Víctor S. Rangel: Advanced Endovascular Management in Severe Postpartum CVST
-
Oct 3, 2026, 08:05Are Circadian Rhythms Fueling Thrombotic Risk in Space? – RPTH Journal
-
Oct 3, 2026, 07:43Janez Urevc: Modeling Compression Ultrasound for Internal Jugular Vein Thrombosis in Astronauts